论文部分内容阅读
目的观察清肺化痰方治疗婴幼儿哮喘性支气管炎的临床疗效及其对肺功能的影响。方法将157例哮喘性支气管炎患儿随机分为观察组(81例)和对照组(76例),在服用盐酸丙卡特罗口服液的基础上分别给予清肺化痰方和射干合剂,疗程10 d。观察两组临床疗效及治疗前后肺功能变化情况。结果观察组总有效率为93.83%,对照组为86.84%;两组临床疗效无统计学差异(P>0.05)。治疗后,两组Rrs SO均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05);两组Crs SO均较治疗前升高(P<0.05),但两组之间比较无显著性差异(P>0.05)。结论清肺化痰方治疗婴幼儿哮喘性支气管炎临床疗效良好,且能改善肺功能。
Objective To observe the clinical efficacy of Qingfei Huatan Fang in treating infantile asthma bronchitis and its effect on pulmonary function. Methods 157 children with asthmatic bronchitis were randomly divided into observation group (n = 81) and control group (n = 76). The patients were treated with procaterol hydrochloride oral solution on the basis of Qingfei Huatan Fang and Shegan Mixture. The treatment course 10 d. The clinical efficacy and changes of lung function before and after treatment were observed. Results The total effective rate was 93.83% in the observation group and 86.84% in the control group. There was no significant difference in the clinical efficacy between the two groups (P> 0.05). After treatment, the Rrs SO in both groups was lower than that before treatment (P <0.05), and the observation group was lower than the control group (P <0.05). The Crs SO in both groups was significantly higher than that before treatment (P <0.05) There was no significant difference between the two groups (P> 0.05). Conclusion Qingfei Huatan Fang treatment of asthma bronchitis in infants with good clinical efficacy, and can improve lung function.